4-(2-(((8-(tert-butyl)-3,3-dimethyl-3,11-dihydropyrano[3,2-a]carbazol-5-yl)methyl)amino)ethoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide

ID: ALA5285821

Chembl Id: CHEMBL5285821

Max Phase: Preclinical

Molecular Formula: C32H34N4O6S

Molecular Weight: 602.71

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)C=Cc2c(c(CNCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc3c2[nH]c2ccc(C(C)(C)C)cc23)O1

Standard InChI:  InChI=1S/C32H34N4O6S/c1-31(2,3)21-11-12-26-24(18-21)25-17-20(28-23(27(25)34-26)13-14-32(4,5)41-28)19-33-15-16-40-29-30(36(37)42-35-29)43(38,39)22-9-7-6-8-10-22/h6-14,17-18,33-34H,15-16,19H2,1-5H3

Standard InChI Key:  HAPNCYCNQZJOMP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5285821

    ---

Associated Targets(Human)

MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 602.71Molecular Weight (Monoisotopic): 602.2199AlogP: 5.43#Rotatable Bonds: 8
Polar Surface Area: 133.39Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.77CX LogP: 4.94CX LogD: 4.41
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.18Np Likeness Score: 0.07

References

1. Zang Y, Huang L, Chen X, Li C, Ma J, Chen X, Zhang D, Lai F..  (2022)  Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.,  244  [PMID:36270090] [10.1016/j.ejmech.2022.114832]

Source